Benzer Vaccination Programs: Great Shots for Quality “One-on-One” Time with Your Pharmacist

| August 19, 2019

article image
Like the kick-off of the NFL in the fall, the flu season may still be months away, but it’s always a good idea to circle a date on your calendar for getting up-to-date with immunizations. That, of course, goes double if you’re aged 59-or-older. It’s never comforting news to learn that your sensitivity to various strains of the disease only grows over time, but it’s something everyone needs to account for. The basic benefits of getting a flu shot are well-established. Yet, what you may not know is that Benzer also offers clinical immunization services for pneumonia and the shingles. Both can cause severe discomfort, and even death, in those at risk of developing complications or unexpected consequences as new, more volatile subspecies crisscross their way from country-to-country, state-to-state, and person-to-person.

Spotlight

Pharmaceutical Strategies Group - PSG

Pharmaceutical Strategies Group (PSG) is the largest independent pharmacy benefit consulting firm in the U.S. We provide strategic advisory, consulting, analytics, clinical, and administrative solutions to hospitals and health systems, health plans, self-funded employers, Taft-Hartley Funds, and other healthcare purchasers. PSG’s unique approach and expert staff use PSG’s proprietary intellectual property and technology resources to reduce costs, enhance revenue, and optimize health outcomes associated with prescription drug and patient/population management programs.

OTHER ARTICLES

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | April 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 17, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 17, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Spotlight

Pharmaceutical Strategies Group - PSG

Pharmaceutical Strategies Group (PSG) is the largest independent pharmacy benefit consulting firm in the U.S. We provide strategic advisory, consulting, analytics, clinical, and administrative solutions to hospitals and health systems, health plans, self-funded employers, Taft-Hartley Funds, and other healthcare purchasers. PSG’s unique approach and expert staff use PSG’s proprietary intellectual property and technology resources to reduce costs, enhance revenue, and optimize health outcomes associated with prescription drug and patient/population management programs.

Events